Birchview Capital’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.46M | Hold |
310,930
| – | – | 1.45% | 20 |
|
|
2025
Q1 | $1.13M | Hold |
310,930
| – | – | 0.99% | 23 |
|
|
2024
Q4 | $1.47M | Sell |
310,930
-10,000
| -3% | -$47.2K | 1.19% | 21 |
|
|
2024
Q3 | $2.99M | Hold |
320,930
| – | – | 2.59% | 11 |
|
|
2024
Q2 | $1.85M | Hold |
320,930
| – | – | 1.71% | 16 |
|
|
2024
Q1 | $2.15M | Hold |
320,930
| – | – | 1.76% | 14 |
|
|
2023
Q4 | $2.07M | Buy |
320,930
+56,087
| +21% | +$362K | 1.62% | 13 |
|
|
2023
Q3 | $1.32M | Hold |
264,843
| – | – | 1.13% | 17 |
|
|
2023
Q2 | $1.86M | Hold |
264,843
| – | – | 1.4% | 14 |
|
|
2023
Q1 | $1.64M | Hold |
264,843
| – | – | 1.29% | 13 |
|
|
2022
Q4 | $1.69M | Hold |
264,843
| – | – | 1.19% | 15 |
|
|
2022
Q3 | $2.27M | Sell |
264,843
-20,000
| -7% | -$172K | 1.6% | 12 |
|
|
2022
Q2 | $3.87M | Sell |
284,843
-9,300
| -3% | -$126K | 2.82% | 5 |
|
|
2022
Q1 | $4.48M | Sell |
294,143
-20,000
| -6% | -$305K | 3.23% | 6 |
|
|
2021
Q4 | $7.18M | Hold |
314,143
| – | – | 4.63% | 6 |
|
|
2021
Q3 | $4.38M | Hold |
314,143
| – | – | 2.98% | 6 |
|
|
2021
Q2 | $3.35M | Hold |
314,143
| – | – | 2.01% | 9 |
|
|
2021
Q1 | $4.14M | Hold |
314,143
| – | – | 2.46% | 7 |
|
|
2020
Q4 | $6.37M | Buy |
+314,143
| New | +$6.37M | 3.67% | 6 |
|